| The Changes in Matrix Metalloproteinase-1 (MMP-1), Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) and Oxidized LDL Levels During the First 48 Hours in Patients with Acute Coronary Syndrome | Banu ÖNVURAL, Önder KIRIMLI, Ünsal ÜNÜVAR, Bahri AKDENİZ, Pınar AKAN | 43–50 |
| Evaluating Pregnancy-Associated Plasma Protein A (PAPP-A) and Insulin-like growth factor I (IGF-I) Levels in Patients with Acute Coronary Syndrome | Bünyamin KAPTANOĞLU, Hülya AYBEK, Mert ÖZEN, Şahika EREN ÖZEN, Mahmut ŞENYURT | 51–57 |
| Pregnancy Associated Plasma Protein A and C-reactive Protein in Pre-Eclamptic Pregnants | Veli MİHMANLI, Gökhan UTKU, Müberra VARDAR, Yüksel ÖZBANAZI GÜLEN, Hatice Birgül AYABAKAN, Hülya ÇERÇİ, Ekrem ÖZAKIN, Sembol YILDIRMAK TÜRKMEN | 59–66 |
| Sample Stability in Vitamin D Analysis by Liquid Chromatography Tandem Mass Spectrometry | Sedat ABUFLOĞLU, Sevilay SEZER, Turan TURHAN, Muhittin SERDAR, Metin YILDIRIMKAYA, Evren AKGÖL, Hüseyin TuĞrul ÇELİK, Cevdet ZÜNGÜN | 67–72 |
| The Effect of Coronary Angiography on Total Antioxidant Capacity | Serap ÇUHADAR, Ayşenur ATAY, Mehmet KÖSEOĞLU, Serdar BAYATA, Tuna SEMERCİ, Filiz AKÇAY AKYILDIZ, Tuğba AYDIN KANTAROĞLU | 73–78 |
| (AMH) Anti-Mullerian Hormone (AMH): As the Best Marker of Ovarian Reserve | Meltem DEMİR | 79–85 |